141 related articles for article (PubMed ID: 34061369)
1. Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?
Turgeon MK; Lee RM; Keilson JM; Ju MR; Porembka MR; Alterio RE; Kronenfeld J; Datta J; Goel N; Wang A; Lee AY; Fernandez M; Richter H; Maker AV; Maithel SK; Russell MC
J Surg Oncol; 2021 Sep; 124(4):551-559. PubMed ID: 34061369
[TBL] [Abstract][Full Text] [Related]
2. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
3. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
4. Trends in the use and impact of neoadjuvant chemotherapy on perioperative outcomes for resected gastric cancer: Evidence from the American College of Surgeons National Cancer Database.
Greenleaf EK; Hollenbeak CS; Wong J
Surgery; 2016 Apr; 159(4):1099-112. PubMed ID: 26704785
[TBL] [Abstract][Full Text] [Related]
5. Factors contributing to variation in the use of multimodality treatment in patients with gastric cancer: A Dutch population based study.
Beck N; Busweiler LAD; Schouwenburg MG; Fiocco M; Cats A; Voncken FEM; Wijnhoven BPL; van Berge Henegouwen MI; Wouters MWJM; van Sandick JW;
Eur J Surg Oncol; 2018 Feb; 44(2):260-267. PubMed ID: 29273212
[TBL] [Abstract][Full Text] [Related]
6. Perioperative chemotherapy versus adjuvant chemotherapy strategies in resectable gastric and gastroesophageal cancer: A Markov decision analysis.
Choi M; Ishizawa S; Kraemer D; Sasson A; Feinberg E
Eur J Surg Oncol; 2022 Feb; 48(2):403-410. PubMed ID: 34446344
[TBL] [Abstract][Full Text] [Related]
7. Equivalent Treatment and Survival after Resection of Pancreatic Cancer at Safety-Net Hospitals.
Dhar VK; Hoehn RS; Kim Y; Xia BT; Jung AD; Hanseman DJ; Ahmad SA; Shah SA
J Gastrointest Surg; 2018 Jan; 22(1):98-106. PubMed ID: 28849353
[TBL] [Abstract][Full Text] [Related]
8. Perioperative chemotherapy versus adjuvant chemotherapy in patients with resectable gastric cancer: A systematic review with meta-analysis.
Wei C; Du X; Hu J; Dong Y; Chen Y; Cao B
Crit Rev Oncol Hematol; 2024 Jun; 198():104082. PubMed ID: 37532103
[TBL] [Abstract][Full Text] [Related]
9. Identifying the barriers to gastric cancer care at safety-net hospitals: A novel comparison of a safety-net hospital to a neighboring quaternary referral academic center in the same healthcare system.
Zaidi MY; Rappaport JM; Ethun CG; Gillespie T; Hawk N; Chawla S; Cardona K; Maithel SK; Russell MC
J Surg Oncol; 2019 Jan; 119(1):64-70. PubMed ID: 30481370
[TBL] [Abstract][Full Text] [Related]
10. Real-life data on improvement of survival after perioperative chemotherapy versus surgery alone on resectable adenocarcinoma of the stomach - a single-center study.
Kuhnle PJ; Israel KF; Menges M
Z Gastroenterol; 2019 May; 57(5):606-610. PubMed ID: 31083749
[TBL] [Abstract][Full Text] [Related]
11. Colorectal Cancer Safety Net: Is It Catching Patients Appropriately?
Althans AR; Brady JT; Times ML; Keller DS; Harvey AR; Kelly ME; Patel ND; Steele SR
Dis Colon Rectum; 2018 Jan; 61(1):115-123. PubMed ID: 29219921
[TBL] [Abstract][Full Text] [Related]
12. Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East.
Fujitani K
Dig Surg; 2013; 30(2):119-29. PubMed ID: 23867588
[TBL] [Abstract][Full Text] [Related]
13. Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysis.
Kronenfeld JP; Collier AL; Turgeon MK; Ju M; Alterio R; Wang A; Fernandez M; Porembka MR; Richter H; Lee AY; Russell MC; Merchant NB; Maker AV; Datta J
J Surg Oncol; 2021 Dec; 124(8):1317-1328. PubMed ID: 34379324
[TBL] [Abstract][Full Text] [Related]
14. Impact of Neoadjuvant Chemotherapy Among Patients with Pancreatic Fistula After Gastrectomy for Advanced Gastric Cancer.
Kosaka T; Akiyama H; Makino H; Kimura J; Takagawa R; Ono HA; Kunisaki C; Endo I
Anticancer Res; 2016 Apr; 36(4):1773-7. PubMed ID: 27069158
[TBL] [Abstract][Full Text] [Related]
15. Survival inequity in vulnerable populations with early-stage hepatocellular carcinoma: a United States safety-net collaborative analysis.
Kronenfeld JP; Ryon EL; Goldberg D; Lee RM; Yopp A; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Russell MC; Merchant NB; Goel N
HPB (Oxford); 2021 Jun; 23(6):868-876. PubMed ID: 33487553
[TBL] [Abstract][Full Text] [Related]
16. Surgical resection of early stage hepatocellular carcinoma improves patient survival at safety net hospitals.
Vitiello GA; Wang A; Lee RM; Russell MC; Yopp A; Ryon EL; Goel N; Luu S; Hsu C; Silberfein E; Correa-Gallego C; Berman RS; Lee AY
J Surg Oncol; 2021 Mar; 123(4):963-969. PubMed ID: 33497478
[TBL] [Abstract][Full Text] [Related]
17. Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study.
Su P; Jiang L; Zhang Y; Yu T; Huang H; Chen M; Cao C; Kang W; Liu Y; Yu J
Eur J Med Res; 2023 Oct; 28(1):409. PubMed ID: 37814327
[TBL] [Abstract][Full Text] [Related]
18. National Underutilization of Neoadjuvant Chemotherapy for Gastric Cancer.
Liu N; Xu Y; Rahnemai-Azar AA; Abbott DE; Weber SM; Lidor AO
J Gastrointest Surg; 2020 Apr; 24(4):949-958. PubMed ID: 31792901
[TBL] [Abstract][Full Text] [Related]
19. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.
Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ
World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
